Skip to main content
. 1997 Apr 15;94(8):3966–3971. doi: 10.1073/pnas.94.8.3966

Figure 2.

Figure 2

Survival of leukemic SCID mice treated with different doses of thioate or amidate c-myc AS-ODNs. Mice injected with 106 HL-60 cells were treated intravenously 7 days later with 900, 300, or 100 μg/day for 6 consecutive days with □, c-myc phosphorothioate MM-ODN; ▵, c-myc phosphoramidate MM-ODN; ▪, c-myc phosphorothioate AS-ODN; or ▴, c-myc phosphoramidate AS-ODN. Control mice (○) received diluent only. Five mice were included in each group.